Saturday, June 13, 2026
🇺🇸 FDA

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Chinese Academy of clinical programs — 1328 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Chinese Academy of projects

1,328 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 1,328 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,328 programs

Clinical programs

Page 10 of 28

  1. Obinutuzumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Marginal Zone Lymphoma

    phase 2 small molecule active

    1 trial

  2. Obinutuzumab Injection [Gazyva]

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    2 trials

  3. Olverembatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

    phase 2 small molecule completed

    1 trial

  4. Olverembatinib+INO

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HSCT

    phase 2 small molecule active

    1 trial

  5. Open Mini-Laparotomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hydrocephalus

    phase 2 other active

    1 trial

  6. Oral levetiracetam

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Neonatal Seizures

    phase 2 small molecule terminated

    1 trial

  7. Orelabrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Follicular Lymphoma

    phase 2 small molecule active

    1 trial

  8. PBSC

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stem Cell Transplantation, Hematopoietic

    phase 2 mab active

    1 trial

  9. PBSC transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cirrhosis

    phase 2 other active

    1 trial

  10. PD-1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer Patients

    phase 2 small molecule active

    1 trial

  11. PD-1 inhbitor+SHR0302

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  12. PEX168 or placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes

    phase 2 small molecule completed

    1 trial

  13. PG2

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Stroke

    phase 2 small molecule completed

    1 trial

  14. PI3K inhibitor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lymphoma, T-Cell

    phase 2 small molecule active

    1 trial

  15. PIK3CA inhibitor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Neoplasm

    phase 2 small molecule active

    1 trial

  16. PM8002

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Locally Advanced Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  17. Pancreatoduodenectomy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pancreatic Cancer

    phase 2 other active

    1 trial

  18. Pectin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Slow Transit Constipation

    phase 2 small molecule active

    1 trial

  19. Pembrolizumab 200 mg IV infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stage IIIB(N2) Non-small Cell Lung Cancer

    phase 2 mab active

    1 trial

  20. Pemetrexe

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Central Nervous System Tumors

    phase 2 small molecule active

    1 trial

  21. Prednisone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Langerhans Cell Histiocytosis of Bone

    phase 2 small molecule active

    1 trial

  22. QAMS-containing PMMA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Health

    phase 2 other completed

    1 trial

  23. QL1706

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Platinum-resistant Recurrent Ovarian Cancer

    phase 2 small molecule active

    1 trial

  24. Qinbudan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Tuberculosis

    phase 2 small molecule completed

    1 trial

  25. Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-induced Oral Mucositis

    phase 2 small molecule active

    1 trial

  26. Qishen Granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Heart Failure

    phase 2 small molecule active

    1 trial

  27. Qizhi weitong granules(High）

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Irritable Bowel Syndrome

    phase 2 small molecule active

    1 trial

  28. R-EPOCH in Combination With Ibrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Richter Transformation

    phase 2 small molecule active

    1 trial

  29. RC48- ADC

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance

    phase 2 small molecule active

    1 trial

  30. RD14-01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor

    phase 2 mab active

    1 trial

  31. REGEND001 cell therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule completed

    1 trial

  32. Recombinant COVID-19 Vaccine (CHO cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    phase 2 mab active

    1 trial

  33. Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-08)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    phase 2 mab active

    1 trial

  34. Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 mab active

    1 trial

  35. Recombinant Interferon Alpha

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Essential Thrombocytopenia

    phase 2 small molecule active

    2 trials

  36. Regorafenib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Regorafenib

    phase 2 small molecule active

    1 trial

  37. Remote ischemic preconditioning (RIPC)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cerebrovascular Disease

    phase 2 other completed

    1 trial

  38. Rezvilutamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Hormone-Sensitive Prostate Cancer

    phase 2 small molecule active

    1 trial

  39. Rifaximin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Small Intestine Bacterial Overgrowth

    phase 2 small molecule active

    1 trial

  40. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Severe Aplastic Anemia

    phase 2 small molecule active

    1 trial

  41. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  42. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diffuse Large B Cell Lymphoma

    phase 2 small molecule active

    1 trial

  43. Rituximab Paclitaxel Ruxolitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Diffuse Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial

  44. Rituximab combined with Daratumumab（Anti-CD38 Monoclonal Antibody）

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  45. Romiplostim

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia (ITP)

    phase 2 small molecule completed

    1 trial

  46. Ruxolitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    aGVHD

    phase 2 small molecule completed

    1 trial

  47. Ruxolitinib 5 MG BID Oral Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA

    phase 2 small molecule active

    1 trial

  48. S1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Gastric Adenocarcinoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

1,328 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.